Skip to main content
Fig. 4 | Egyptian Journal of Radiology and Nuclear Medicine

Fig. 4

From: Efficiency of whole-body positron emission tomography/computed tomography using 18F-Fluorodeoxyglucose in detecting the cause of elevated cancer antigen 125 serum level in treated ovarian cancer patients

Fig. 4

A 45-year-old female patient with history of bilateral ovarian cancer, submitted for TAH BSO, followed by CTH 1 year ago, presented with recently elevated CA 15.3 and CA 125 serum levels. (a) Whole body PET MIP image revealed multiple metabolically active scattered abdominal and pelvic lesions. CECT (b, c, d and e) and corresponding fused PET/CT (f, g, h and i) images revealed newly developed multiple peritoneal discrete soft tissue nodules unevenly distributed in the peritoneal cavity more appreciated in the paracolic reflections (yellow arrows), achieving up to 5.5 SUVmax, representing peritoneal deposits. Other de novo left external and right internal iliac FDG avid LNs (green arrows), achieving up to 9.2 SUVmax, denoting nodal deposits

Back to article page